Follow
Thomas A. Simpatico, MD
Thomas A. Simpatico, MD
University of Vermont, Center for Clinical & Translational Science and Department of Psychiatry
Verified email at uvm.edu
Title
Cited by
Cited by
Year
Quality of life: An approach integrating opportunities, human needs, and subjective well-being
R Costanza, B Fisher, S Ali, C Beer, L Bond, R Boumans, NL Danigelis, ...
Ecological economics 61 (2-3), 267-276, 2007
15792007
An integrative approach to quality of life measurement, research, and policy
R Costanza, B Fisher, S Ali, C Beer, L Bond, R Boumans, NL Danigelis, ...
SAPI EN. S. Surveys and Perspectives Integrating Environment and Society, 2008
3562008
The addictive brain: all roads lead to dopamine
K Blum, ALC Chen, J Giordano, J Borsten, TJH Chen, M Hauser, ...
Journal of psychoactive drugs 44 (2), 134-143, 2012
1852012
rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts
K Blum, Y Liu, W Wang, Y Wang, Y Zhang, M Oscar-Berman, A Smolen, ...
Postgraduate medicine 127 (2), 232-241, 2015
1022015
Neurogenetics and nutrigenomics of neuro-nutrient therapy for reward deficiency syndrome (RDS): clinical ramifications as a function of molecular neurobiological mechanisms
K Blum, M Oscar-Berman, E Stuller, D Miller, J Giordano, S Morse, ...
Journal of addiction research & therapy 3 (5), 139, 2012
782012
Staff training to improve implementation and impact of behavioral rehabilitation programs.
PW Corrigan, SG McCracken, M Edwards, S Kommana, T Simpatico
Psychiatric services (Washington, DC) 48 (10), 1336-1338, 1997
641997
Long term Suboxone™ emotional reactivity as measured by automatic detection in speech
E Hill, D Han, P Dumouchel, N Dehak, T Quatieri, C Moehs, ...
PLoS one 8 (7), e69043, 2013
462013
Systematic evaluation of “compliance” to prescribed treatment medications and “abstinence” from psychoactive drug abuse in chemical dependence programs: data from the …
K Blum, D Han, J Femino, DE Smith, S Saunders, T Simpatico, ...
PLoS One 9 (9), e104275, 2014
442014
Vermont responds to its opioid crisis
TA Simpatico
Preventive medicine 80, 10-11, 2015
422015
Neurogenetic impairments of brain reward circuitry links to reward deficiency syndrome (RDS): Potential nutrigenomic induced dopaminergic activation
K Blum, M Oscar-Berman, J Giordano, BW Downs, T Simpatico, D Han, ...
Journal of genetic syndrome & gene therapy 3 (4), 2012
422012
Common neurogenetic diagnosis and meso-limbic manipulation of hypodopaminergic function in reward deficiency syndrome (RDS): Changing the recovery landscape
K Blum, M Febo, R D Badgaiyan, Z Demetrovics, T Simpatico, C Fahlke, ...
Current Neuropharmacology 15 (1), 184-194, 2017
412017
Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential?
K Blum, TJH Chen, J Bailey, A Bowirrat, J Femino, ALC Chen, T Simpatico, ...
Molecular neurobiology 44, 250-268, 2011
402011
The mothers' project for homeless mothers with mental illnesses and their children: a pilot study.
P Hanrahan, ML McCoy, L Cloninger, J Dincin, MA Zeitz, TA Simpatico, ...
Psychiatric Rehabilitation Journal 28 (3), 291, 2005
402005
Putative dopamine agonist (KB220Z) attenuates lucid nightmares in PTSD patients: Role of enhanced brain reward functional connectivity and homeostasis redeeming joy
T McLaughlin, K Blum, M Oscar-Berman, M Febo, G Agan, JL Fratantonio, ...
Journal of Behavioral Addictions 4 (2), 106-115, 2015
392015
Withdrawal from buprenorphine/naloxone and maintenance with a natural dopaminergic agonist: A cautionary note
K Blum, M Oscar-Berman, J Femino, RL Waite, L Benya, J Giordano, ...
Journal of addiction research & therapy 4 (2), 2013
372013
Hypothesizing music intervention enhances brain functional connectivity involving dopaminergic recruitment: common neuro-correlates to abusable drugs
K Blum, T Simpatico, M Febo, C Rodriquez, K Dushaj, M Li, ...
Molecular neurobiology 54 (5), 3753-3758, 2017
332017
In search of reward deficiency syndrome (RDS)-free controls: the “holy grail” in genetic addiction risk testing
K Blum, D Baron, L Lott, JV Ponce, D Siwicki, B Boyett, B Steinberg, ...
Current psychopharmacology 9 (1), 7-21, 2020
322020
Reward deficiency syndrome (RDS) surprisingly is evolutionary and found everywhere: is it “blowin’in the wind”?
K Blum, T McLaughlin, A Bowirrat, EJ Modestino, D Baron, LL Gomez, ...
Journal of personalized medicine 12 (2), 321, 2022
272022
Have we hatched the addiction egg: reward deficiency syndrome solution system™
BW Downs, M Oscar-Berman, RL Waite, MA Madigan, J Giordano, ...
Journal of genetic syndrome & gene therapy 4 (136), 14318, 2013
272013
Staff perceptions about barriers to innovative behavioral rehabilitation programs
PW Corrigan, SG McCracken, S Kommana, M Edwards, T Simpatico
Cognitive therapy and research 20, 541-551, 1996
271996
The system can't perform the operation now. Try again later.
Articles 1–20